Provided By GlobeNewswire
Last update: Jul 17, 2025
MALVERN, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss the Company’s second quarter 2025 financial results and provide a business update at 8:30 a.m. ET on Friday, August 1, 2025.
Read more at globenewswire.comNASDAQ:OCGN (7/23/2025, 9:38:00 AM)
1.07
+0.04 (+3.88%)
Find more stocks in the Stock Screener